Imogen J. Swift

1.3k total citations
8 papers, 184 citations indexed

About

Imogen J. Swift is a scholar working on Physiology, Neurology and Neurology. According to data from OpenAlex, Imogen J. Swift has authored 8 papers receiving a total of 184 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 5 papers in Neurology and 4 papers in Neurology. Recurrent topics in Imogen J. Swift's work include Alzheimer's disease research and treatments (6 papers), Amyotrophic Lateral Sclerosis Research (4 papers) and Neurological diseases and metabolism (2 papers). Imogen J. Swift is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Amyotrophic Lateral Sclerosis Research (4 papers) and Neurological diseases and metabolism (2 papers). Imogen J. Swift collaborates with scholars based in United Kingdom, Sweden and Italy. Imogen J. Swift's co-authors include Jonathan D. Rohrer, Aitana Sogorb‐Esteve, Henrik Zetterberg, Amanda Heslegrave, Carolin Heller, Markus Otto, Daniela Galimberti, Emily Todd, John C. van Swieten and Matthis Synofzik and has published in prestigious journals such as Journal of Neurology Neurosurgery & Psychiatry, Neurobiology of Aging and Movement Disorders.

In The Last Decade

Imogen J. Swift

8 papers receiving 182 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Imogen J. Swift United Kingdom 7 83 65 60 37 32 8 184
Raúl Núñez‐Llaves Spain 6 75 0.9× 15 0.2× 79 1.3× 61 1.6× 23 0.7× 9 205
Lisa M. Häsler Germany 6 185 2.2× 38 0.6× 118 2.0× 60 1.6× 27 0.8× 7 268
RoseMarie Brundin Sweden 10 169 2.0× 47 0.7× 100 1.7× 74 2.0× 48 1.5× 13 261
Florent Letronne United States 8 121 1.5× 27 0.4× 96 1.6× 104 2.8× 13 0.4× 8 258
Alexander Svanbergsson Sweden 8 63 0.8× 81 1.2× 77 1.3× 43 1.2× 6 0.2× 10 208
N.J. Cairns United Kingdom 8 175 2.1× 44 0.7× 133 2.2× 28 0.8× 45 1.4× 13 265
Silvana Geracitano Italy 11 104 1.3× 50 0.8× 111 1.9× 29 0.8× 22 0.7× 18 232
Vincent Huin France 10 70 0.8× 67 1.0× 100 1.7× 47 1.3× 15 0.5× 19 232
Duc M. Duong United States 8 77 0.9× 22 0.3× 108 1.8× 31 0.8× 28 0.9× 16 245
Kate Duberley United Kingdom 6 74 0.9× 101 1.6× 224 3.7× 42 1.1× 7 0.2× 7 364

Countries citing papers authored by Imogen J. Swift

Since Specialization
Citations

This map shows the geographic impact of Imogen J. Swift's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imogen J. Swift with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imogen J. Swift more than expected).

Fields of papers citing papers by Imogen J. Swift

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imogen J. Swift. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imogen J. Swift. The network helps show where Imogen J. Swift may publish in the future.

Co-authorship network of co-authors of Imogen J. Swift

This figure shows the co-authorship network connecting the top 25 collaborators of Imogen J. Swift. A scholar is included among the top collaborators of Imogen J. Swift based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imogen J. Swift. Imogen J. Swift is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Meda, Francisco J., Imogen J. Swift, Aitana Sogorb‐Esteve, et al.. (2023). Neurofilament light oligomers in neurodegenerative diseases: quantification by homogeneous immunoassay in cerebrospinal fluid. BMJ Neurology Open. 5(1). e000395–e000395. 11 indexed citations
2.
Magen, Iddo, Jason D. Warren, Carolin Heller, et al.. (2023). microRNA‐based predictor for diagnosis of frontotemporal dementia. Neuropathology and Applied Neurobiology. 49(4). e12916–e12916. 6 indexed citations
3.
Swift, Imogen J., Simon Sjödin, Johan Gobom, et al.. (2023). Differential patterns of lysosomal dysfunction are seen in the clinicopathological forms of primary progressive aphasia. Journal of Neurology. 271(3). 1277–1285. 3 indexed citations
4.
Sogorb‐Esteve, Aitana, Imogen J. Swift, Ione Woollacott, et al.. (2021). Differential chemokine alteration in the variants of primary progressive aphasia—a role for neuroinflammation. Journal of Neuroinflammation. 18(1). 224–224. 15 indexed citations
5.
Swift, Imogen J., Aitana Sogorb‐Esteve, Carolin Heller, et al.. (2020). Fluid biomarkers in frontotemporal dementia: past, present and future. Journal of Neurology Neurosurgery & Psychiatry. 92(2). 204–215. 83 indexed citations
6.
Swift, Imogen J., Martina Bocchetta, Hanya Benotmane, et al.. (2020). Variable clinical phenotype in TBK1 mutations: case report of a novel mutation causing primary progressive aphasia and review of the literature. Neurobiology of Aging. 99. 100.e9–100.e15. 14 indexed citations
7.
Shribman, Samuel, Carolin Heller, Maggie Burrows, et al.. (2020). Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease. Movement Disorders. 36(2). 503–508. 23 indexed citations
8.
Palombo, Francesca, Francesco Tamagnini, J. Charles G. Jeynes, et al.. (2017). Detection of Aβ plaque-associated astrogliosis in Alzheimer's disease brain by spectroscopic imaging and immunohistochemistry. The Analyst. 143(4). 850–857. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026